Lonza | LONN - Ebitda

Aktienkurs
479.80
Täglich Wechseln
-19.30 -3.87%
Monatlich
-1.19%
Jährlich
-16.38%
Q2 Prognose
470.40




Ebitda Veränderung Datum
Akzo Nobel EUR 345M 540M 2026-03
Alcon AG USD 317M 337M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
BASF EUR 1.54B 228M 2025-09
Bayer EUR 1.97B 457M 2025-12
Beiersdorf EUR 984M 147M 2025-06
Covestro EUR 242M 24M 2025-09
Demant DKK 2.76B 165M 2025-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Geberit CHF 177.6M 58.4M 2025-12
Genmab DKK 186M 291M 2025-12
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 3.36B 179M 2025-09
GN Store Nord DKK 627M 106M 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Johnson Matthey GBP 325M 52M 2024-06
Merck EUR 1.44B 263M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Philips EUR 738M 9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
Sika AG CHF 994.3M 76.1M 2025-12
Smith & Nephew USD 796M 139M 2025-12
Solvay EUR 169M 63M 2025-12
UCB EUR 1.6B 570M 2025-12